Keymed Biosciences consistently explore the disease areas that need to be solved urgently, focus on the autoimmune and tumor therapies, establish a highly competitive pipeline, and rapidly promote the R&D of multiple innovative drugs.
Projects under R&D
Entered Clinical Stage
Meet the GMP Standards of NMPA, FDA and EMA
Efficiently Synthesize the Internal Development and Production Capability, Establish a Comprehensive and Integrated Biological R&D Platform
Innovation Runs through the Whole Industrial Chain of R&D, Production and Future Commercial Operation